Descrizione del progetto
Un modo intelligente di migliorare la diagnosi e la terapia del tumore colorettale
Si prevede che l’intelligenza artificiale consentirà di personalizzare il trattamento del tumore colorettale e di ridurne i tassi di incidenza e mortalità, ed è questo l’obiettivo del progetto OperA, finanziato dall’UE. In particolare, il progetto effettuerà uno studio randomizzato basato sulla popolazione su scala europea per stabilire il valore della colonscopia assistita da IA per la prevenzione del cancro colorettale. In generale, l’obiettivo del progetto è quello di migliorare drasticamente la cura del tumore del colon-retto. OperA produrrà inoltre uno strumento di previsione del rischio per un trattamento personalizzato e modelli efficaci in termini di costi della colonscopia assistita dall’IA nello screening del cancro colorettale. Per di più, il progetto cercherà di abbattere le barriere a livello etico e giuridico che si frappongono allo sviluppo e all’implementazione dell’IA.
Obiettivo
Integration of artificial intelligence (AI) technologies into clinical medicine has been hampered by challenges related to uncertain long-term clinical benefits, cost-effectiveness, and ethics/legal concerns. Application of AI in colonoscopy, a forefront research topic, has been also bothered by these issues. AI is, however, expected to reduce colorectal cancer incidence and mortality through personalised treatment. Our proposed project would change this discouraging situation and thus drastically improves colorectal cancer care. We achieve the following goals:
1. Establish the value of AI-assisted colonoscopy in colorectal cancer prevention by conducting a pan-European,
population-based, randomised trial with 222,000 participants.
2. Develop a colonoscopy AI risk-prediction tool for personalized treatment of colorectal polyps and cancer.
3. Develop cost-effectiveness models of AI-assisted colonoscopy in colorectal cancer screening.
4. Investigate ethical and legal barriers in AI development and implementation.
5. Generate the first trustworthy and rapidly updating (?living?) clinical guidelines for AI in screening colonoscopy.
6. Develop a patient-oriented AI tool by including end-users in the process of AI development and communication.
Our research consortium maximises the feasibility of the project, with world-class experts in gastroenterology, machine learning, cancer screening, biostatistics, disease modelling, regulatory science, and ethics and law in medicine from nine European countries, the US and Japan. We also partner with a European medium-size AI enterprise for implementing the output of the project. The project has large potential impact on patients, society, and economy in Europe, and the World. Up to 6,000 fewer deaths due to colorectal cancer and saving of 720 million euro can be expected per year once the technology is widely accepted in Europe.
Campo scientifico
Parole chiave
Programma(i)
Meccanismo di finanziamento
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinatore
0313 Oslo
Norvegia